Duke NewCo Opportunities

Poryphrin Technologies: A new class of molecules that prevent side-effects in radiation therapy .
Contact: Bryan Baines  

NeuroScience Pharmaceuticals: Pipeline of neurosteroid drugs with a lead compound now in fully funded phase II clinical trial for the treatment of schizophrenia and proof-of-concept clinical trials for treatment of post-traumatic stress disorder and traumatic brain injury.
Contact: Brandy Salmon

ENO: Clinical Development of Ethyl Nitrite, a gas with numerous potential indications.
Contact: Brandy Salmon

Bio Artificial Cartilage for Joint Resurfacing
Contact: Amy Collinsworth

Receptor coupled electronic biosensors: A new class of biosensors enabled by novel processes to place biochemical reagents (both organic and inorganic) on surfaces to detect analyte reactions.
Contact: Bryan Baines

CancerGuideDX: Molecular diagnostics for the enablement of individualized cancer therapy.
Contact: Bryan Baines